Registration number: 10965433

Ettelocin Limited

Contents

Company Information	1
Director's Report	2
Balance Sheet	3
Notes to the Unaudited Financial Statements	4 to 7

Ettelocin Limited

Company Information





 

Director

N Grobler

Registered office

No 18 T8/9 Brooke's Mill Armitage Bridge Huddersfield West Yorkshire HD4 7NR

Accountants

D & A Hill No.18 T8/9 Brooke's Mill Armitage Bridge Huddersfield West Yorkshire HD4 7NR

Ettelocin Limited

Director's Report
for the Year Ended 30 September 2025

The director presents her report and the financial statements for the year ended 30 September 2025.

Director of the company

The director who held office during the year was as follows:

N Grobler

Principal activity

The principal activity of the company is providing office administration services.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 8 June 2026
 

......................................... N Grobler Director

Ettelocin Limited

(Registration number: 10965433 )
Balance Sheet as at 30 September 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	1,932	907
Current assets
Debtors	5	2,164	2,033
Cash at bank and in hand		18,776	60
		20,940	2,093
Creditors: Amounts falling due within one year	6	(21,174)	(37,386)
Net current liabilities		(234)	(35,293)
Net assets/(liabilities)		1,698	(34,386)
Capital and reserves
Called up share capital	7	1	1
Retained earnings		1,697	(34,387)
Shareholders' funds/(deficit)		1,698	(34,386)

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account and Director's Report.

Approved and authorised by the director on 8 June 2026
 

......................................... N Grobler Director

Ettelocin Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
No 18 T8/9 Brooke's Mill
Armitage Bridge
Huddersfield
West Yorkshire
HD4 7NR
England

These financial statements were authorised for issue by the director on 8 June 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Ettelocin Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office and computer equipment	25% reducing balance

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2024 - 1).

Ettelocin Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2025

4	Tangible assets

	Office equipment £	Total £
Cost or valuation
At 1 October 2024	6,425	6,425
Additions	1,669	1,669
At 30 September 2025	8,094	8,094
Depreciation
At 1 October 2024	5,518	5,518
Charge for the year	644	644
At 30 September 2025	6,162	6,162
Carrying amount
At 30 September 2025	1,932	1,932
At 30 September 2024	907	907

5

Debtors

Current	2025 £	2024 £
Other debtors	2,164	2,033
	2,164	2,033

6

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Accruals and deferred income	480	564
Other creditors	20,694	36,822
	21,174	37,386

Ettelocin Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2025

7	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
Ordinary of £1 each	1	1	1	1